COEP
Coeptis Therapeutics Inc

3,003
Mkt Cap
$85.23M
Volume
17,374.00
52W High
$19.19
52W Low
$2.31
PE Ratio
-4.04
COEP Fundamentals
Price
$16.42
Prev Close
$15.96
Open
$16.18
50D MA
$15.23
Beta
0.48
Avg. Volume
38,397.65
EPS (Annual)
-$5.65
P/B
6.60
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Coeptis Therapeutics (NASDAQ:COEP) Stock Price Up 12.2% - What's Next?
Coeptis Therapeutics (NASDAQ:COEP) Stock Price Up 12.2% - Time to Buy...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration
COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration COEPTIS Completes $10 Million Series A Preferred Financing...
PR Newswire·10mo ago
News Placeholder
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation PR...
PR Newswire·10mo ago
News Placeholder
Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation
Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation...
PR Newswire·10mo ago
News Placeholder
Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform
Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform PR Newswire...
PR Newswire·11mo ago
News Placeholder
Coeptis Therapeutics Announces Reverse Stock Split
Coeptis Therapeutics Announces Reverse Stock Split Coeptis Therapeutics Announces Reverse Stock Split PR Newswire WEXFORD, Pa., Dec. 27, 2024 WEXFORD, Pa., Dec. 27, 2024 /PRNewswire/ -- Coeptis...
PR Newswire·11mo ago
News Placeholder
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies Coeptis Therapeutics Makes Bold Strides in...
PR Newswire·11mo ago
News Placeholder
Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies
Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies PR Newswire WEXFORD, Pa., Dec. 12, 2024 Coeptis...
PR Newswire·11mo ago
News Placeholder
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development Coeptis Therapeutics Announces...
PR Newswire·1y ago
News Placeholder
Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use
Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic...
PR Newswire·1y ago

Latest COEP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.